GlassScriptPhysician profile
Mansoor Tanwir
NPI 1538322664
$53,453.49
in general payments reported to CMS, 2019-2025
39 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $25.73 · 2021: $36.84 · 2022: $1,231 · 2023: $13K · 2024: $20K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $11K · Travel and Lodging: $6,056 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,931 · Honoraria: $4,130 · Consulting Fee: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,506.26 |
| Food and Beverage | $11,207.67 |
| Travel and Lodging | $6,055.78 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,931.26 |
| Honoraria | $4,130.00 |
| Consulting Fee | $975.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $37,800.18 | 2022-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $5,434.12 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Medtronic Minimed, INC. | $1,286.90 | 2019 | |
| Dexcom, INC. | $928.13 | 2021-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $903.62 | 2022-2025 | Korlym |
| Lilly USA, LLC | $847.11 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Tandem Diabetes Care, INC. | $618.31 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $571.09 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $485.88 | 2019-2025 | |
| Novo Nordisk INC | $482.88 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Insulet Corporation | $381.16 | 2022-2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.95 | 2022-2025 | Jardiance, Synjardy |
| Amgen INC. | $369.25 | 2024-2025 | Tepezza, Evenity, Repatha |
| Recordati_rare_diseases_inc. | $304.24 | 2024-2025 | Isturisa, Signifor Lar |
| Medtronic, INC. | $257.24 | 2022-2024 | Minimed 780g |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $222.10 | 2022-2025 | Tirosint, Licart, Tirosint |
| Abbvie INC. | $211.40 | 2022-2025 | Synthroid |
| Sequel Med Tech, LLC | $201.06 | 2025 | Twiist |
| Ascensia Diabetes Care US INC. | $195.14 | 2022-2024 | |
| Mannkind Corporation | $189.04 | 2023-2025 | Afrezza |
| Chiesi USA, INC. | $177.08 | 2024-2025 | Mycapssa |
| Radius Health, INC. | $174.66 | 2023-2025 | Tymlos |
| Horizon Therapeutics Plc | $147.43 | 2023 | Tepezza |
| Cequr Corporation | $116.82 | 2023-2025 | Cequr Simplicity |
| Ascendis Pharma Endocrinology INC | $116.42 | 2023-2025 | Yorvipath |
| Beta Bionics, INC. | $97.79 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Nevro Corp. | $93.65 | 2023-2024 | Senza |
| Novartis Pharmaceuticals Corporation | $74.34 | 2024 | |
| Antares Pharma, INC. | $70.56 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Alexion Pharmaceuticals, INC. | $69.48 | 2024-2025 | Strensiq |
| Kyowa Kirin, INC. | $69.01 | 2024 | Crysvita |
| Astellas Pharma US INC | $47.28 | 2024-2025 | Veozah |
| Pfizer INC. | $35.25 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $24.74 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $22.38 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $20.37 | 2022 | |
| Acella Pharmaceuticals, LLC | $14.62 | 2025 | NP Thyroid 60 |
| Lifescan, INC. | $13.81 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansoor Tanwir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.